Mix to Validate: A Facile, Reversible PEGylation for Fast Screening of Potential Therapeutic Proteins In Vivo

Site-Specific PEGylation at Histidine Tags

(2012) Yuehua Cong et al.   BIOCONJUGATE CHEMISTRY

Role of Hexahistidine in Directed Nanoassemblies of Tobacco Mosaic Virus Coat Protein

(2011) Michael A. Bruckman et al.   ACS Nano

Multifunctional Poly(ethylene glycol)s

(2011) Boris Obermeier et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

PEGylated TNF-Related Apoptosis-Inducing Ligand (TRAIL) Analogues: Pharmacokinetics and Antitumor Effects

(2011) Tae Hyung Kim et al.   BIOCONJUGATE CHEMISTRY

PEGylated TNF-related apoptosis-inducing ligand (TRAIL) for effective tumor combination therapy

(2011) Hai Hua Jiang et al.   BIOMATERIALS

State of the art in PEGylation: The great versatility achieved after forty years of research

(2011) Gianfranco Pasut et al.   JOURNAL OF CONTROLLED RELEASE

TRAIL-mediated signaling in prostate, bladder and renal cancer

(2011) Christina Voelkel-Johnson   Nature Reviews Urology

Multivalent and Flexible PEG-Nitrilotriacetic Acid Derivatives for Non-covalent Protein Pegylation

(2011) Anna Mero et al.   PHARMACEUTICAL RESEARCH

Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives

(2010) Katrin Knop et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Improved Antitumor Activity and Tumor Targeting of NH2-Terminal-Specific PEGylated Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand

(2010) S. Y. Chae et al.   MOLECULAR CANCER THERAPEUTICS

Emerging PEGylated drugs

(2009) Jung Seok Kang et al.   EXPERT OPINION ON EMERGING DRUGS

High-Affinity Labeling and Tracking of Individual Histidine-Tagged Proteins in Live Cells Using Ni2+Tris-nitrilotriacetic Acid Quantum Dot Conjugates

(2009) Victor Roullier et al.   NANO LETTERS

Ligand-Based Targeting of Apoptosis in Cancer: The Potential of Recombinant Human Apoptosis Ligand 2/Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (rhApo2L/TRAIL)

(2008) Avi Ashkenazi et al.   JOURNAL OF CLINICAL ONCOLOGY